0001969223-23-000395.txt : 20231003 0001969223-23-000395.hdr.sgml : 20231003 20231003154927 ACCESSION NUMBER: 0001969223-23-000395 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 231303265 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: Tessier-Lavigne Marc CENTRAL INDEX KEY: 0001437435 FILING VALUES: FORM TYPE: 144 MAIL ADDRESS: STREET 1: 1 DNA WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 144 1 primary_doc.xml 144 0001437435 XXXXXXXX LIVE 0000872589 Regeneron Pharmaceuticals, Inc. 000-19034 777 Old Saw Mill River Road Tarrytown NY 10591-6717 9148477000 Marc Tessier-Lavigne Former Board of Director Common Stock UBS Financial Services Inc

1000 Harbor Blvd 3rd Floor Weehawken NJ 07086

16362 13184270.53 106740572 10/03/2023 NASDAQ Common Stock 10/03/2023 Stock Option Exercise Company N 16362 10/03/2023 Cash Y 10/03/2023 /s/ UBS Financial Services Inc, as attorney-in-fact for Marc Tessier-Lavigne